127 related articles for article (PubMed ID: 22783374)
1. The clinical usefulness of urinary N(1),N(12)-diacetylspermine (DiAcSpm) levels as a tumor marker in patients with colorectal cancer.
Nakayama Y; Torigoe T; Minagawa N; Yamaguchi K
Oncol Lett; 2012 May; 3(5):970-974. PubMed ID: 22783374
[TBL] [Abstract][Full Text] [Related]
2. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
3. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
4. Determination of N¹,N¹²-diacetylspermine in urine: a novel tumor marker.
Kawakita M; Hiramatsu K; Yanagiya M; Doi Y; Kosaka M
Methods Mol Biol; 2011; 720():367-78. PubMed ID: 21318886
[TBL] [Abstract][Full Text] [Related]
5. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T
Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers].
Kawakita M; Hiramatsu K; Sugimoto M; Takahashi K; Toi M
Rinsho Byori; 2004 Apr; 52(4):321-7. PubMed ID: 15164599
[TBL] [Abstract][Full Text] [Related]
7. Urinary N
Yokota K; Hinoki A; Hiramatsu K; Amano H; Kawamura M; Kuwatsuka Y; Tainaka T; Shirota C; Sumida W; Makita S; Okamoto M; Takimoto A; Yasui A; Nakagawa Y; Uchida H; Kawakita M
Pediatr Surg Int; 2021 Dec; 37(12):1659-1665. PubMed ID: 34453590
[TBL] [Abstract][Full Text] [Related]
8. Excretion of N(1), N(12)-diacetylspermine in the urine of healthy individuals.
Hiramatsu K; Sakaguchi K; Fujie N; Saitoh F; Takahama E; Moriya SS; Iwasaki K; Sakaguchi M; Takahashi K; Kawaikta M
Ann Clin Biochem; 2014 Jul; 51(Pt 4):459-67. PubMed ID: 23963052
[TBL] [Abstract][Full Text] [Related]
9. Construction of an immunochromatographic determination system for N¹,N¹²-diacetylspermine.
Moriya SS; Hiramatsu K; Kimura E; Matsumoto K; Kawakita M
J Clin Lab Anal; 2014 Nov; 28(6):452-60. PubMed ID: 24659188
[TBL] [Abstract][Full Text] [Related]
10. Increase of N1, N12-diacetylspermine in tissues from colorectal cancer and its liver metastasis.
Kuwata G; Hiramatsu K; Samejima K; Iwasaki K; Takahashi K; Koizumi K; Horiguchi S; Moriya SS; Kobayashi M; Kawakita M
J Cancer Res Clin Oncol; 2013 Jun; 139(6):925-32. PubMed ID: 23443255
[TBL] [Abstract][Full Text] [Related]
11. N1, N12-Diacetylspermine Is Elevated in Colorectal Cancer and Promotes Proliferation through the miR-559/CBS Axis in Cancer Cell Lines.
Mu T; Chu T; Li W; Dong Q; Liu Y
J Oncol; 2021; 2021():6665704. PubMed ID: 34603448
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.
Enjoji M; Nakamuta M; Arimura E; Morizono S; Kuniyoshi M; Fukushima M; Kotoh K; Nawata H
Int J Biol Markers; 2004; 19(4):322-7. PubMed ID: 15646840
[TBL] [Abstract][Full Text] [Related]
13. [The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer].
Takahashi K; Hiramatsu K; Kawakita M; Mori T; Yamaguchi T; Matsumoto H; Miyamoto H; Tamamori Y
Rinsho Byori; 2004 Apr; 52(4):332-5. PubMed ID: 15164601
[TBL] [Abstract][Full Text] [Related]
14. Diacetylated derivatives of spermine and spermidine as novel promising tumor markers.
Kawakita M; Hiramatsu K
J Biochem; 2006 Mar; 139(3):315-22. PubMed ID: 16567395
[TBL] [Abstract][Full Text] [Related]
15. [Estimation of urinary diacetylspermine in Yusho patients].
Shibata S; Tokunaga S; Furue M
Fukuoka Igaku Zasshi; 2007 May; 98(5):136-40. PubMed ID: 17642287
[TBL] [Abstract][Full Text] [Related]
16. Identification and determination of urinary acetylpolyamines in cancer patients by electrospray ionization and time-of-flight mass spectrometry.
Samejima K; Hiramatsu K; Takahashi K; Kawakita M; Kobayashi M; Tsumoto H; Kohda K
Anal Biochem; 2010 Jun; 401(1):22-9. PubMed ID: 20178772
[TBL] [Abstract][Full Text] [Related]
17. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
18. Meprin α combined with CEA and CA19-9 improves prognostic prediction for surgically treated colorectal cancer patients.
Hou H; Gou X; Bu J; Su Y; Wei X; Wang X; Hou B
Int J Clin Exp Pathol; 2017; 10(10):10441-10450. PubMed ID: 31966381
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
Grotowski M; Maruszyński M; Piechota W
Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
[TBL] [Abstract][Full Text] [Related]
20. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
